NetScientific is an active transatlantic life sciences, sustainability and technology investment and commercialisation group.
NSCI confirms that further to its announcement of 6 May 2022, that it completed yesterday its acquisition of a 30 % stake in Vortex - a commercial stage Trans-Atlantic company which has developed and launched the VTX-1 platform servicing the liquid biopsy, cell analytics and oncology markets. The Vortex microfluidics technology captures intact, viable circulating tumo ....
16 Aug 2022
WH Ireland: NetScientific (NSCI) - Completes the acquisition of 30% of Vortex Biotech Holdings
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
WH Ireland: NetScientific (NSCI) - Completes the acquisition of 30% of Vortex Biotech Holdings
NetScientific plc (NSCI:LON) | 67.0 -1.3 (-2.9%) | Mkt Cap: 16.0m
- Published:
16 Aug 2022 -
Author:
Matthew Davis | Emma Ulker -
Pages:
4
NetScientific is an active transatlantic life sciences, sustainability and technology investment and commercialisation group.
NSCI confirms that further to its announcement of 6 May 2022, that it completed yesterday its acquisition of a 30 % stake in Vortex - a commercial stage Trans-Atlantic company which has developed and launched the VTX-1 platform servicing the liquid biopsy, cell analytics and oncology markets. The Vortex microfluidics technology captures intact, viable circulating tumo ....